Clinical Trial Update: Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the efficacy and safety of an intravitreal VEGF trap-eye in patients with polyploidal choroidal vasculopathy (PCV) without active poly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• intravitreal vascular endothelial growth factor trap-eye

Snippet

Sponsor: Samsung Medical Center | Conditions: Polypoidal Choroidal Vasculopathy Without Active Polyp | Phase 4 | Status: COMPLETED